Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Int J Mol Sci ; 15(3): 4431-41, 2014 Mar 13.
Artigo em Inglês | MEDLINE | ID: mdl-24633197

RESUMO

The immune system, particularly T lymphocytes and cytokines, has been implicated in the progression of brain injury after intracerebral hemorrhage (ICH). Although studies have shown that transplanted neural stem cells (NSCs) protect the central nervous system (CNS) from inflammatory damage, their effects on subpopulations of T lymphocytes and their corresponding cytokines are largely unexplored. Here, rats were subjected to ICH and NSCs were intracerebrally injected at 3 h after ICH. The profiles of subpopulations of T cells in the brain and peripheral blood were analyzed by flow cytometry. We found that regulatory T (Treg) cells in the brain and peripheral blood were increased, but γδT cells (gamma delta T cells) were decreased, along with increased anti-inflammatory cytokines (IL-4, IL-10 and TGF-ß) and decreased pro-inflammatory cytokines (IL-6, and IFN-γ), compared to the vehicle-treated control. Our data suggest that transplanted NSCs protect brain injury after ICH via modulation of Treg and γδT cell infiltration and anti- and pro-inflammatory cytokine release.


Assuntos
Hemorragia Cerebral/imunologia , Citocinas/imunologia , Células-Tronco Neurais/imunologia , Linfócitos T Reguladores/imunologia , Linfócitos T/imunologia , Animais , Encéfalo/irrigação sanguínea , Encéfalo/imunologia , Encéfalo/patologia , Células Cultivadas , Hemorragia Cerebral/sangue , Hemorragia Cerebral/terapia , Ensaio de Imunoadsorção Enzimática , Citometria de Fluxo , Interferon gama/sangue , Interferon gama/imunologia , Interleucina-10/sangue , Interleucina-10/imunologia , Interleucina-4/sangue , Interleucina-4/imunologia , Interleucina-6/sangue , Interleucina-6/imunologia , Masculino , Camundongos Endogâmicos C57BL , Células-Tronco Neurais/transplante , Ratos Sprague-Dawley , Receptores de Antígenos de Linfócitos T gama-delta/imunologia , Receptores de Antígenos de Linfócitos T gama-delta/metabolismo , Transplante de Células-Tronco/métodos , Linfócitos T/metabolismo , Fator de Crescimento Transformador beta/sangue , Fator de Crescimento Transformador beta/imunologia , Transplante Heterólogo
2.
CNS Neurosci Ther ; 20(4): 317-26, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24393245

RESUMO

AIMS: Intravenous transplantation of bone marrow mesenchymal stem cells (BMSCs) had been documented to improve functional outcome after ischemic stroke. However, the timing and appropriate cell number of transplantation to achieve better outcome after an episode of stroke remain further to be optimized. METHODS: To determine the optimal conditions, we transplanted different concentrations of BMSCs at different time points in a rat model of ischemic stroke. Infarction volume and neurological behavioral tests were performed after ischemia. RESULTS: We found that transplantation of BMSCs at 3 and 24 h, but not 7 days after focal ischemia, significantly reduced the lesion volume and improved motor deficits. We also found that transplanted cells at 1 × 10(6) to 10(7) , but not at 1 × 10(4) to 10(5) , significantly improved functional outcome after stroke. In addition to inhibiting macrophages/microglia activation in the ischemic brain, BMSC transplantation profoundly reduced infiltration of gamma delta T (γδT) cells, which are detrimental to the ischemic brain, and significantly increased regulatory T cells (Tregs), along with altered Treg-associated cytokines in the ischemic brain. CONCLUSIONS: Our data suggest that timing and cell dose of transplantation determine the therapeutic effects after focal ischemia by modulating poststroke neuroinflammation.


Assuntos
Isquemia Encefálica/imunologia , Isquemia Encefálica/cirurgia , Transplante de Células-Tronco Mesenquimais/métodos , Acidente Vascular Cerebral/imunologia , Acidente Vascular Cerebral/cirurgia , Adulto , Animais , Encéfalo/imunologia , Encéfalo/patologia , Encéfalo/cirurgia , Isquemia Encefálica/patologia , Células Cultivadas , Citocinas/metabolismo , Modelos Animais de Doenças , Humanos , Infarto da Artéria Cerebral Média/imunologia , Infarto da Artéria Cerebral Média/patologia , Infarto da Artéria Cerebral Média/cirurgia , Macrófagos/fisiologia , Microglia/fisiologia , Pessoa de Meia-Idade , Ratos , Ratos Sprague-Dawley , Recuperação de Função Fisiológica , Acidente Vascular Cerebral/patologia , Linfócitos T/fisiologia , Fatores de Tempo , Resultado do Tratamento
3.
CNS Neurosci Ther ; 19(12): 969-77, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24164711

RESUMO

AIMS: To study whether adiponectin (APN) could improve neurological outcomes in aged mice after ischemic stroke. METHODS: Adeno-associated virus carrying APN gene was injected into aged and young adult mice 7 days before transient middle cerebral artery occlusion (tMCAO). Atrophic volumes and neurobehavioral deficiencies were determined up to 28 days after tMCAO. Focal angiogenesis was determined based on blood vessel number in the ischemic regions. RESULTS: Increased atrophic volume and more sever neurobehavioral deficits were found in the aged mice compared with young adult mice (P < 0.05). AAV-APN gene transfer attenuated atrophic volume and improved neurobehavioral outcomes, along with increased focal angiogenesis in both aged and young adult mice, compared with control animals (P < 0.05). In addition, the attenuation of atrophic volume and the improvement in neurobehavioral outcomes were much more significant in aged mice than in young adult mice after AAV-APN administration (P < 0.05). The number of microvessels in aged AAV-APN mouse ischemic brain was higher than in young adult AAV-APN treated mouse brain (P < 0.05). CONCLUSIONS: Our results demonstrate that APN overexpression reduces ischemic brain injury and improves neurobehavioral function recovery in aged mice than in young mice, suggesting APN is more beneficial in aged animals after ischemic stroke.


Assuntos
Adiponectina/metabolismo , Envelhecimento , Isquemia Encefálica/complicações , Regulação da Expressão Gênica/fisiologia , Transtornos Mentais/etiologia , Transtornos Mentais/terapia , Adenoviridae/genética , Adiponectina/genética , Fatores Etários , Animais , Modelos Animais de Doenças , Masculino , Camundongos , Microvasos/metabolismo , Microvasos/patologia , Fosfopiruvato Hidratase/metabolismo , Molécula-1 de Adesão Celular Endotelial a Plaquetas/metabolismo , Antígeno Nuclear de Célula em Proliferação/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA